Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Klotho Neurosciences ( (KLTO) ) is now available.
On December 2, 2025, Klotho Neurosciences entered into a Securities Purchase Agreement with Sigma9 Capital, Ltd. The agreement involves the issuance and sale of 3,400 shares of a new class of Series C Preferred Stock at $4,400 per share. Each share is convertible into 10,000 shares of common stock, with restrictions on conversion to prevent exceeding ownership limits and compliance with Nasdaq rules. The transaction was made under an exemption from registration, based on a pre-existing relationship and the investor’s capability to assess investment risks.
More about Klotho Neurosciences
Average Trading Volume: 1,494,724
Technical Sentiment Signal: Sell
Current Market Cap: $36.34M
See more data about KLTO stock on TipRanks’ Stock Analysis page.